These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38686441)

  • 1. The relationship between clinical presentation and the nature of care in adults with intellectual disability and epilepsy - national comparative cohort study.
    Badger S; Watkins LV; Bassett P; Roy A; Eyeoyibo M; Sawhney I; Purandare K; Wood L; Pugh A; Hammett J; Sheehan R; Tromans S; Shankar R
    BJPsych Open; 2024 Apr; 10(3):e94. PubMed ID: 38686441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study.
    Sun JJ; Perera B; Henley W; Angus-Leppan H; Sawhney I; Watkins L; Purandare KN; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Ashby S; De Silva R; Miller J; Philpott DE; Ashwin C; Howkins J; Slater H; Medhurst D; Shankar R
    J Neurol; 2022 May; 269(5):2750-2760. PubMed ID: 35067759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling increased risks in older adults with intellectual disability and epilepsy: Data from a national multicentre cohort study.
    Watkins LV; Henley W; Sun JJ; Perera B; Angus-Leppan H; Sawhney I; Purandare K; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Shankar R
    Seizure; 2022 Oct; 101():15-21. PubMed ID: 35850018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of comorbidity and psychopharmacology in adults with intellectual disability and attention deficit hyperactivity disorder: an UK national cross-sectional audit.
    Perera B; Chen J; Korb L; Borakati A; Courtenay K; Henley W; Tromans S; Shankar R
    Expert Opin Pharmacother; 2021 Jun; 22(8):1071-1078. PubMed ID: 33487043
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. People with epilepsy and intellectual disability: More than a sum of two conditions.
    Snoeijen-Schouwenaars FM; Young C; Rowe C; van Ool JS; Schelhaas HJ; Shankar R
    Epilepsy Behav; 2021 Oct; 124():108355. PubMed ID: 34624802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of antiseizure medications prescribing in people with intellectual disability and epilepsy: A narrative review and analysis.
    Branford D; Sun JJ; Burrows L; Shankar R
    Br J Clin Pharmacol; 2023 Jul; 89(7):2028-2038. PubMed ID: 37060156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
    Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
    Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case-control study.
    Sun JJ; Watkins L; Henley W; Laugharne R; Angus-Leppan H; Sawhney I; Shahidi MM; Purandare K; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Perera B; Hyams B; Ashby S; Shankar R
    J Neurol; 2023 Jul; 270(7):3527-3536. PubMed ID: 37022478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services.
    Naqvi D; Perera B; Mitchell S; Sheehan R; Shankar R
    BJPsych Open; 2021 Dec; 8(1):e7. PubMed ID: 34865678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between early childhood onset epilepsy and attention-deficit hyperactivity disorder (ADHD) in 3237 children and adolescents with Autism Spectrum Disorder (ASD): a historical longitudinal cohort data linkage study.
    Carson L; Parlatini V; Safa T; Baig B; Shetty H; Phillips-Owen J; Prasad V; Downs J
    Eur Child Adolesc Psychiatry; 2023 Nov; 32(11):2129-2138. PubMed ID: 35927526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilepsy in adults with neurodevelopmental disability - what every neurologist should know.
    Watkins LV; Linehan C; Brandt C; Snoeijen-Schouwenaars F; McGowan P; Shankar R
    Epileptic Disord; 2022 Feb; 24(1):9-25. PubMed ID: 34750095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables.
    Espie CA; Watkins J; Curtice L; Espie A; Duncan R; Ryan JA; Brodie MJ; Mantala K; Sterrick M
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1485-92. PubMed ID: 14617702
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.